Extracellular vesicles as a next-generation drug delivery platform

Facebook
Twitter
LinkedIn
  • van der Meel, R. et al. Smart cancer nanomedicine. Nat. Nanotechnol. 14, 1007–1017 (2019).

    Article  CAS  Google Scholar

  • Elsharkasy, O. M. et al. Extracellular vesicles as drug delivery systems: why and how? Adv. Drug Deliv. Rev. 159, 332–343 (2020).
  • Möller, A. & Lobb, R. J. The evolving translational potential of small extracellular vesicles in cancer. Nat. Rev. Cancer 20, 697–709 (2020).
  • El Andaloussi, S., Mager, I., Breakefield, X. O. & Wood, M. J. A. Extracellular vesicles: biology and emerging therapeutic opportunities. Nat. Rev. Drug Discov. 12, 347–357 (2013).

    CAS  Article  Google Scholar

  • Mathieu, M., Martin-Jaular, L., Lavieu, G. & Théry, C. Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication. Nat. Cell Biol. 21, 9–17 (2019).

    CAS  Article  Google Scholar

  • Hoppstädter, J. et al. Toll-like receptor 2 release by macrophages: an anti-inflammatory program induced by glucocorticoids and lipopolysaccharide. Front. Immunol. 10, 1634 (2019). This original work presented one of the first examples of modifying EVs with polyethylene glycol and the influence on in vivo biodistribution of vesicles.
  • Kooijmans, S. A. A. et al. PEGylated and targeted extracellular vesicles display enhanced cell specificity and circulation time. J. Control. Release 224, 77–85 (2016).

    CAS  Article  Google Scholar

  • Woith, E., Fuhrmann, G. & Melzig, M. F. Extracellular vesicles—connecting kingdoms. Int. J. Mol. Sci. 20, 5695 (2019).

    CAS  Article  Google Scholar

  • Kalluri, R. & LeBleu, V. S. The biology, function, and biomedical applications of exosomes. Science 367, eaau6977 (2020).

    CAS  Article  Google Scholar

  • Witwer, K. W. & Théry, C. Extracellular vesicles or exosomes? On primacy, precision, and popularity influencing a choice of nomenclature. J. Extracell. Vesicles 8, 1648167–1648167 (2019).

    Article  Google Scholar

  • Cabeza, L. et al. Cancer therapy based on extracellular vesicles as drug delivery vehicles. J. Control. Release 327, 296–315 (2020).

    CAS  Article  Google Scholar

  • Théry, C. et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J. Extracell. Vesicles 7, 1535750 (2018).

    Article  Google Scholar

  • O’Brien, K., Breyne, K., Ughetto, S., Laurent, L. C. & Breakefield, X. O. RNA delivery by extracellular vesicles in mammalian cells and its applications. Nat. Rev. Mol. Cell Biol. 21, 585–606 (2020).

    CAS  Article  Google Scholar

  • Tkach, M., Kowal, J. & Théry, C. Why the need and how to approach the functional diversity of extracellular vesicles. Phil. Trans. R. Soc. B 373, 20160479 (2018).

    Article  CAS  Google Scholar

  • Hurwitz, S. N. et al. Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers. Oncotarget 7, 86999–87015 (2016).

    Article  Google Scholar

  • Rocha, S. et al. 3D cellular architecture affects microRNA and protein cargo of extracellular vesicles. Adv. Sci. 6, 1800948 (2019).

    Article  CAS  Google Scholar

  • Fuhrmann, G., Herrmann, I. & Stevens, M. M. Cell-derived vesicles for drug therapy and diagnostics: opportunities and challenges. Nano Today 10, 397–409 (2015).

    CAS  Article  Google Scholar

  • Gross, J. C., Chaudhary, V., Bartscherer, K. & Boutros, M. Active Wnt proteins are secreted on exosomes. Nat. Cell Biol. 14, 1036–1045 (2012).

    CAS  Article  Google Scholar

  • Smith, S. A., Selby, L. I., Johnston, A. P. R. & Such, G. K. The endosomal escape of nanoparticles: toward more efficient cellular delivery. Bioconjugate Chem. 30, 263–272 (2019).

    CAS  Article  Google Scholar

  • van den Boorn, J. G., Schlee, M., Coch, C. & Hartmann, G. SiRNA delivery with exosome nanoparticles. Nat. Biotechnol. 29, 325–326 (2011).

    Article  CAS  Google Scholar

  • Sung, B. H. et al. A live cell reporter of exosome secretion and uptake reveals pathfinding behavior of migrating cells. Nat. Commun. 11, 2092 (2020).

    CAS  Article  Google Scholar

  • Xu, R. et al. Extracellular vesicles in cancer—implications for future improvements in cancer care. Nat. Rev. Clin. Oncol. 15, 617–638 (2018).

    CAS  Article  Google Scholar

  • Ricklefs, F. L. et al. Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles. Sci. Adv. 4, eaar2766 (2018).

    Article  CAS  Google Scholar

  • Keklikoglou, I. et al. Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models. Nat. Cell Biol. 21, 190–202 (2019).

    CAS  Article  Google Scholar

  • Nolte-‘t Hoen, E., Cremer, T., Gallo, R. C. & Margolis, L. B. Extracellular vesicles and viruses: are they close relatives? Proc. Natl Acad. Sci. USA 113, 9155–9161 (2016).

    Article  CAS  Google Scholar

  • Toyofuku, M., Nomura, N. & Eberl, L. Types and origins of bacterial membrane vesicles. Nat. Rev. Microbiol. 17, 13–24 (2019).

    CAS  Article  Google Scholar

  • Mehanny, M., Koch, M., Lehr, C.-M. & Fuhrmann, G. Streptococcal extracellular membrane vesicles are rapidly internalized by immune cells and alter their cytokine release. Front. Immunol. 11, 80 (2020).
  • Goes, A. et al. Myxobacteria-derived outer membrane vesicles: potential applicability against intracellular infections. Cells 9, 194 (2020).

    CAS  Article  Google Scholar

  • Gujrati, V. et al. Bioengineered bacterial outer membrane vesicles as cell-specific drug-delivery vehicles for cancer therapy. ACS Nano 8, 1525–1537 (2014).

    CAS  Article  Google Scholar

  • Kuhn, T., Koch, M. & Fuhrmann, G. Probiomimetics—novel lactobacillus-mimicking microparticles show anti-inflammatory and barrier-protecting effects in gastrointestinal models. Small 16, 2003158 (2020).

    CAS  Article  Google Scholar

  • Murali, V. P. & Holmes, C. A. Biomaterial-based extracellular vesicle delivery for therapeutic applications. Acta Biomater. 124, 88–107 (2021).

    CAS  Article  Google Scholar

  • Pourtalebi Jahromi, L. & Fuhrmann, G. Bacterial extracellular vesicles: understanding biology promotes applications as nanopharmaceuticals. Adv. Drug Deliv. Rev. 173, 125–140 (2021).
  • Ayers, L., Pink, R., Carter, D. R. F. & Nieuwland, R. Clinical requirements for extracellular vesicle assays. J. Extracell. Vesicles 8, 1593755 (2019).
  • Nassar, W. et al. Umbilical cord mesenchymal stem cells derived extracellular vesicles can safely ameliorate the progression of chronic kidney diseases. Biomater. Res. 20, 21 (2016).

    Article  CAS  Google Scholar

  • Wang, J., Bonacquisti, E. E., Brown, A. D. & Nguyen, J. Boosting the biogenesis and secretion of mesenchymal stem cell-derived exosomes. Cells 9, 660 (2020).

    CAS  Article  Google Scholar

  • Kou, X. et al. The Fas/Fap-1/Cav-1 complex regulates IL-1RA secretion in mesenchymal stem cells to accelerate wound healing. Sci. Transl. Med. 10, eaai8524 (2018).

    Article  CAS  Google Scholar

  • Public Safety Notification on Exosome Products (FDA, 2019); www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/public-safety-notification-exosome-products
  • Lener, T. et al. Applying extracellular vesicles based therapeutics in clinical trials—an ISEV position paper. J. Extracell. Vesicles 4, 30087 (2015). A seminal position paper from an international consortium of EV scientists on the regulatory needs when studying vesicles in clinical trials.

    Article  CAS  Google Scholar

  • Börger, V. et al. International Society for Extracellular Vesicles and International Society for Cell and Gene Therapy statement on extracellular vesicles from mesenchymal stromal cells and other cells: considerations for potential therapeutic agents to suppress coronavirus disease-19. Cytotherapy 22, 482–485 (2020).

    Article  CAS  Google Scholar

  • Galipeau, J. The mesenchymal stromal cells dilemma—does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road? Cytotherapy 15, 2–8 (2013).

    Article  Google Scholar

  • Witwer, K. W. et al. Defining mesenchymal stromal cell (MSC)-derived small extracellular vesicles for therapeutic applications. J. Extracell. Vesicles 8, 1609206 (2019).
  • Rohde, E., Pachler, K. & Gimona, M. Manufacturing and characterization of extracellular vesicles from umbilical cord-derived mesenchymal stromal cells for clinical testing. Cytotherapy 21, 581–592 (2019). This perspective provides a roadmap for the development of EV-based therapeutics in a very early stage of manufacturing as well as during early clinical safety and proof-of-concept testing.

    Article  Google Scholar

  • Zipkin, M. Exosome redux. Nat. Biotechnol. 37, 1395–1400 (2019).

    CAS  Article  Google Scholar

  • Chuo, S. T.-Y., Chien, J. C.-Y. & Lai, C. P.-K. Imaging extracellular vesicles: current and emerging methods. J. Biomed. Sci. 25, 91 (2018).

    CAS  Article  Google Scholar

  • Zeev-Ben-Mordehai, T., Vasishtan, D., Siebert, C. A., Whittle, C. & Grünewald, K. Extracellular vesicles: a platform for the structure determination of membrane proteins by cryo-EM. Structure 22, 1687–1692 (2014).

    CAS  Article  Google Scholar

  • Kreimer, S. et al. Mass-spectrometry-based molecular characterization of extracellular vesicles: lipidomics and proteomics. J. Proteome Res 14, 2367–2384 (2015).

    CAS  Article  Google Scholar

  • Van Deun, J. et al. EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research. Nat. Methods 14, 228–232 (2017).

    Article  CAS  Google Scholar

  • Welsh, J. A. et al. Towards defining reference materials for measuring extracellular vesicle refractive index, epitope abundance, size and concentration. J. Extracell. Vesicles 9, 1816641 (2020). This paper provides guidelines on the standardization of commonly used analysis platforms for characterizing EV refractive index, epitope abundance, size and concentration.

    Article  Google Scholar

  • Valadi, H. et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654–659 (2007).

    CAS  Article  Google Scholar

  • Alvarez-Erviti, L. et al. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat. Biotechnol. 29, 341–345 (2011).

    CAS  Article  Google Scholar

  • Mittelbrunn, M. et al. Unidirectional transfer of micro RNA-loaded exosomes from T cells to antigen-presenting cells. Nat. Commun. 2, 282 (2011).

    Article  CAS  Google Scholar

  • Murphy, D. E. et al. Natural or synthetic RNA delivery: a stoichiometric comparison of extracellular vesicles and synthetic nanoparticles. Nano Lett. 21, 1888–1895 (2021).

    CAS  Article  Google Scholar

  • Hoshino, A. et al. Tumour exosome integrins determine organotropic metastasis. Nature 527, 329–335 (2015).

    CAS  Article  Google Scholar

  • Qiao, L. et al. Tumor cell-derived exosomes home to their cells of origin and can be used as Trojan horses to deliver cancer drugs. Theranostics 10, 3474–3487 (2020).

    CAS  Article  Google Scholar

  • Dai, J. et al. Exosomes: key players in cancer and potential therapeutic strategy. Signal Transduct. Target. Ther. 5, 145 (2020).

    CAS  Article  Google Scholar

  • Wiklander, O. P. B. et al. Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting. J. Extracell. Vesicles 4, 26316 (2015).

    Article  Google Scholar

  • Lai, C. P. et al. Dynamic biodistribution of extracellular vesicles in vivo using a multimodal imaging reporter. ACS Nano 8, 483–494 (2014).

    CAS  Article  Google Scholar

  • Henriksen, J. R. et al. Remote loading of 64Cu2+ into liposomes without the use of ion transport enhancers. ACS Appl. Mater. Interfaces 7, 22796–22806 (2015).

    CAS  Article  Google Scholar

  • Johnsen, K. B. et al. On the use of liposome controls in studies investigating the clinical potential of extracellular vesicle-based drug delivery systems—a commentary. J. Control. Release 269, 10–14 (2018).

    CAS  Article  Google Scholar

  • Lenzini, S., Bargi, R., Chung, G. & Shin, J.-W. Matrix mechanics and water permeation regulate extracellular vesicle transport. Nat. Nanotechnol. 15, 217–223 (2020). In this recent work, the influence of mechanical properties of EVs on the diffusion from extracellular-matrix-simulating environments was evaluated.

    CAS  Article  Google Scholar

  • Geigert, J. in The Challenge of CMC Regulatory Compliance for Biopharmaceuticals and Other Biologics (ed. Geigert, J.) 221–237 (Springer, 2013).
  • Somiya, M., Yoshioka, Y. & Ochiya, T. Biocompatibility of highly purified bovine milk-derived extracellular vesicles. J. Extracell. Vesicles 7, 1440132 (2018).

    Article  CAS  Google Scholar

  • McVey, M. J. et al. Platelet extracellular vesicles mediate transfusion-related acute lung injury by imbalancing the sphingolipid rheostat. Blood 137, 690–701 (2021).

    CAS  Article  Google Scholar

  • Balachandran, B. & Yuana, Y. Extracellular vesicles-based drug delivery system for cancer treatment. Cogent Med. 6, 1635806 (2019).

    Article  Google Scholar

  • Robbins, P. D. & Morelli, A. E. Regulation of immune responses by extracellular vesicles. Nat. Rev. Immunol. 14, 195–208 (2014).

    CAS  Article  Google Scholar

  • Mehanny, M., Lehr, C.-M. & Fuhrmann, G. Extracellular vesicles as antigen carriers for novel vaccination avenues. Adv. Drug…

Source